<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(3)</volume><submitter>Yanny B</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Post-COVID-19 cholangiopathy (PCC) is a rare but poorly understood and serious complication of COVID-19 infection. We sought to better understand the epidemiology, mechanism of action, histology, imaging findings, and outcomes of PCC.&lt;h4>Methods&lt;/h4>We searched PubMed, Cochrane Library, Embase, and Web of Science from December 2019 to December 2021. Mesh words used "post-Covid-19 cholangiopathy," "COVID-19 liver injury," "Covid-19 and cholangiopathy," and "COVID-19 liver disease." The data on epidemiology, mechanism of action, histology, imaging findings, and outcomes were collected.&lt;h4>Results&lt;/h4>PCC was reported in 30 cases during the study period. The mean (standard deviation [SD]) age was 53.7 (5). Men accounted for cases (83.3%). All patients had required intensive</pubmed_abstract><journal>Journal of clinical and experimental hepatology</journal><pagination>489-499</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9618303</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Post-COVID-19 Cholangiopathy: A Systematic Review.</pubmed_title><pmcid>PMC9618303</pmcid><pubmed_authors>Yanny B</pubmed_authors><pubmed_authors>Alkhero M</pubmed_authors><pubmed_authors>Stenberg D</pubmed_authors><pubmed_authors>Alani M</pubmed_authors><pubmed_authors>Saab S</pubmed_authors><pubmed_authors>Saharan A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Post-COVID-19 Cholangiopathy: A Systematic Review.</name><description>&lt;h4>Objectives&lt;/h4>Post-COVID-19 cholangiopathy (PCC) is a rare but poorly understood and serious complication of COVID-19 infection. We sought to better understand the epidemiology, mechanism of action, histology, imaging findings, and outcomes of PCC.&lt;h4>Methods&lt;/h4>We searched PubMed, Cochrane Library, Embase, and Web of Science from December 2019 to December 2021. Mesh words used "post-Covid-19 cholangiopathy," "COVID-19 liver injury," "Covid-19 and cholangiopathy," and "COVID-19 liver disease." The data on epidemiology, mechanism of action, histology, imaging findings, and outcomes were collected.&lt;h4>Results&lt;/h4>PCC was reported in 30 cases during the study period. The mean (standard deviation [SD]) age was 53.7 (5). Men accounted for cases (83.3%). All patients had required intensive</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May-Jun</publication><modification>2026-07-14T15:50:16.012Z</modification><creation>2025-04-03T21:30:52.914Z</creation></dates><accession>S-EPMC9618303</accession><cross_references><pubmed>36337085</pubmed><doi>10.1016/j.jceh.2022.10.009</doi></cross_references></HashMap>